Colgate-Palmolive Co(CL) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | S&P 500 | P/E | 34.77 | EPS (ttm) | 2.53 | Insider Own | 0.19% | Shs Outstand | 797.2M | Perf Week | -2.44% |
| Market Cap | 70.07B | Forward P/E | 21.39 | EPS next Y | 6.24% | Insider Trans | -18.64% | Shs Float | 795.6M | Perf Month | -4.78% |
| Enterprise Value | 76.81B | PEG | 3.52 | EPS next Q | 0.93 | Inst Own | 87.09% | Short Float | 2.21% | Perf Quarter | -2.28% |
| Income | 2.04B | P/S | 3.33 | EPS this Y | 4.8% | Inst Trans | -1.65% | Short Ratio | 3.75 | Perf Half Y | -1.91% |
| Sales | 21.05B | P/B | 296.91 | EPS next 5Y | 6.07% | ROA | 11.89% | Short Interest | 17.56M | Perf YTD | 11.24% |
| Book/sh | 0.3 | P/C | 48.23 | EPS past 3/5Y | 7.29% -3.47% | ROE | 434.33% | 52W High | -11.51% ($99.33) | Perf Year | 5.65% |
| Cash/sh | 1.82 | P/FCF | 18.16 | Sales past 3/5Y | 4.29% 4.35% | ROIC | 25.28% | 52W Low | 17.92% ($74.54) | Perf 3Y | 20.08% |
| Dividend Est. | $2.12 (2.41%) | EV/EBITDA | 14.66 | EPS Y/Y TTM | -29.04% | Gross Margin | 60.42% | Volatility(W/M) | 1.57% 1.62% | Perf 5Y | 14.1% |
| Dividend TTM | 2.1 | EV/Sales | 3.65 | Sales Y/Y TTM | 5.24% | Oper. Margin | 21.84% | ATR (14) | 1.64 | Perf 10Y | 24.05% |
| Dividend Ex-Date | 2026/7/20 | Quick Ratio | 0.67 | EPS Q/Q | -5.4% | Profit Margin | 9.68% | RSI (14) | 37.14 | Recom | 1.96 |
| Dividend Gr. 3/5Y | 3.46% 3.32% | Current Ratio | 1.03 | Sales Q/Q | 4.91% | SMA20 | -2.8% ($90.43) | Beta | 0.32 | Target Price | $99.53 |
| Payout | 78.37% | Debt/Eq | 33.29 | Earnings | 2026/7/31 | SMA50 | -4.03% ($91.59) | Rel Volume | 0.77 | Prev Close | $88.03 |
| Employees | 33600 | LT Debt/Eq | 33.15 | EPS/Sales Surpr. | 4.54% 0.06% | SMA200 | 0.05% ($87.86) | Avg Volume(3M) | 4.68M | Price | $87.9 |
| IPO | 1930/3/31 | Option/Short | Yes/Yes | Trades | 38889 | Volume | 3,586,702 | Change | -0.15% |
Company
CL is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🪥 A leading company in the global household goods and personal care industry. Headquartered in New York, USA, this global household products group traces its roots back to 1806 and has been operating businesses across oral care, home care, personal care, and pet nutrition.
Over the past 1 year, roughly in the middle
12% below its 1-year high.
CL has weak earning power
21.84% of revenue is kept as operating profit.
Tap to view numbers
Growth is moderate
Earnings are expected to grow by +4.8% this year.
Tap to view numbers
The price looks about right
Trading at 34.8 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 2 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Buy.
Tap to view numbers
Long-term returns are close to the market
Would have changed by +20.1% if bought 5 years ago.
Tap to view numbers
The dividend is on the small side
Pays 2.41% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 87.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
Special products that amplify (leveraged) or invert this single stock. They decay quickly and are not for long-term holding.
It ranks #3 in the industry
Based on market cap of $70B.
FAQ
What kind of company is CL?
CL belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of CL?
The market cap of CL is approximately $70.1B, ranking 246 within its sector.
Does CL pay dividends?
CL has a dividend yield of approximately 2.41%, with an annual dividend of $2.12.
What is the P/E ratio of CL?
CL has a P/E ratio of approximately 34.8x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for CL?
CL has recorded a 52-week high of $99.33 and a low of $74.54.